Informe completo: Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke: a systematic review and economic evaluation

Resumen: Implantable cardiac monitors after cryptogenic stroke

Objetivo: The objectives were to assess the clinical effectiveness and cost-effectiveness of the BioMonitor 2-AF™ (Biotronik SE & Co. KG, Berlin, Germany), the Confirm Rx™ (Abbott Laboratories, Lake Bluff, IL,USA), and the Reveal LINQ™ (Medtronic plc, Minneapolis, MN, USA) implantable cardiac monitors to detect suspected paroxysmal atrial fibrillation in people who have had a cryptogenic stroke. The review considered the diagnostic accuracy, clinical effectiveness and cost-effectiveness of the three implantable cardiac monitors compared with no further testing after at least 24 hours of outpatient external ambulatory electrocardiography.

Autoría: NIHR Health Technology Assessment programme

Idioma: inglés

Fuente: INAHTA

Año de publicación: 2020